CRISPR Gene Drive Technology Successfully Reverses Antibiotic Resistance in Bacterial Populations
Key Insights
University of California San Diego researchers developed pPro-MobV (search), a novel CRISPR-based technology that spreads between bacteria via conjugal transfer to eliminate antibiotic resistance (search) genes.
The second-generation system demonstrated successful inactivation of ampicillin resistance in bacterial populations and proved effective within challenging biofilm environments.
This breakthrough represents one of the few technologies capable of actively reversing antibiotic resistance (search) spread rather than merely slowing its progression.
University of California San Diego scientists have developed a groundbreaking CRISPR-based technology that can actively reverse antibiotic resistance (search) in bacterial populations, offering new hope in the fight against superbugs (search) that threaten to cause more than 10 million deaths worldwide by 2050.
The research team, led by Professors Ethan Bier and Justin Meyer from UC San Diego's School of Biological Sciences, created a second-generation Pro-Active Genetics (Pro-AG (search)) tool called pPro-MobV (search) that functions similarly to gene drives used in insect populations. Published in the Nature journal npj Antimicrobials and Resistance, the study demonstrates how this innovative approach can spread antibiotic-resistance-eliminating elements throughout bacterial communities.
Novel Mechanism Targets Resistance at Population Level
The pPro-MobV (search) system represents a significant advancement over the team's initial 2019 Pro-AG (search) concept, which was developed in collaboration with Professor Victor Nizet's group at UC San Diego School of Medicine (search). The original technology introduced genetic cassettes that copied between bacterial genomes to inactivate antibiotic-resistant components carried on plasmids - circular DNA molecules that replicate within cells.
"With pPro-MobV (search) we have brought gene-drive thinking from insects to bacteria as a population engineering tool," said Bier, a faculty member in the Department of Cell and Developmental Biology. "With this new CRISPR-based technology we can take a few cells and let them go to neutralize AR in a large target population."
The enhanced system spreads antibiotic CRISPR cassette components via conjugal transfer, exploiting naturally occurring bacterial mating tunnels between cells. This mechanism allows the technology to distribute anti-resistance gene cassettes between bacterial strains effectively.
Demonstrated Efficacy in Challenging Environments
The researchers successfully tested pPro-MobV (search) in bacterial biofilms - communities of microorganisms that contaminate surfaces and prove extremely difficult to eliminate through conventional cleaning methods. Biofilms contribute significantly to disease spread and are present in the majority of infections leading to serious illness, partly because they create protective cellular layers that prevent antibiotic penetration.
In laboratory experiments using Escherichia coli strains, the team demonstrated that conjugal transfer of the pPro-MobV (search) system efficiently inactivated the bla resistance gene (search), which confers ampicillin resistance, thereby reducing antibiotic resistance (search) in recipient cells.
"The biofilm context for combatting antibiotic resistance (search) is particularly important since this is one of the most challenging forms of bacterial growth to overcome in the clinic or in enclosed environments such as aquafarm ponds and sewage treatment plants," Bier explained. "If you could reduce the spread from animals to humans you could have a significant impact on the antibiotic resistance problem since roughly half of it is estimated to come from the environment."
Safety Mechanisms and Delivery Options
The technology incorporates important safety features, including a homology-based deletion process that serves as a CRISPR-driven mechanism for removing gene cassettes when desired. This process precisely targets plasmid DNA flanked by short direct repeats, resulting in deletion of intervening sequences and providing a fail-safe option for controlling the system.
Additionally, researchers found that components of the active genetic system could be delivered by bacteriophages - viruses that naturally compete with bacteria. These engineered phage viruses could work in conjunction with pPro-MobV (search) elements, offering multiple delivery pathways for the resistance-reversing technology.
Addressing Global Health Crisis
With antibiotic resistance (search) currently responsible for approximately 1.27 million deaths worldwide and steadily accelerating to become a global health crisis, the development represents a crucial advancement in combating superbugs (search). These resistant bacteria flourish in hospital settings, sewage treatment areas, animal husbandry locations, and fish farms, creating widespread challenges for public health.
"This technology is one of the few ways that I'm aware of that can actively reverse the spread of antibiotic-resistant genes, rather than just slowing or coping with their spread," said Meyer, a professor in the Department of Ecology, Behavior and Evolution who studies evolutionary adaptations of bacteria and viruses.
The pPro-MobV (search) system's potential applications extend beyond clinical settings to include environmental remediation and microbiome engineering, offering a comprehensive approach to addressing antibiotic resistance (search) across multiple contexts where resistant bacteria pose significant threats to human and environmental health.